International Stem Cell (OTC:ISCO) reported on Thursday that the company’s board of directors have appointed Kurt May as president and Chief Operating Officer.
May, a founder and CEO of privately-held biotech company Psynomics, served on the faculty and was also assistant Dean of the Rady School of Management at the University of California, San Diego from 2005 to 2009.
Prior to joining International Stem Cell, May acted as senior executive with GTE and with PriceSmart (NASDAQ:PSMT).
During his tenure at PriceSmart, May led the company from start-up to growth over three years that included establishing 22 stores in 11 countries, reaching annual sales of more than $500 million, and expanded staff from 356 to more than 4,200.
In a statement, International Stem Cell CEO Andrey Semechkin, said: "May is an extremely capable executive who has managed both a multi-billion dollar public company and a successful life sciences start-up company."
International Stem Cells Co-Founder, Kenneth Aldrich said: "We view May's commercial and entrepreneurial skills as an essential part of our business plan for success."
Additionally, the board of directors also designated Semechkin as co-chairman.
International Stem Cell is a biotechnology company with a focus on the therapeutic applications of human parthenogentic stem cells, and the development and commercialization of cell-based research and cosmetic products.
The company has developed a method to derive stem cells similar to embryonic stem cells without the need for fertilized eggs, called parthenogenesis.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment